Description
DaVita, Inc.: Is Their Expectation Regarding Revenue Per Treatment Growth Reasonable?
DaVita ended 2024 strongly, with adjusted operating income of $1.98 billion and adjusted earnings per share (EPS) growing by 26% year-over-year, reaching $9.68. However, challenges such as the Change Healthcare outage and supply chain disruptions due to Hurricane Helene impacted performance. These issues contributed to a $6 million negative impact on operating income in the fourth quarter.
Our Report Structure:
⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures
Want unlimited access to our reports? Purchase our $99 annual subscription!
